Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 70 of the 70 references it cites were found in a registry or an index.

The Molecular Evolution of Type 2 Vaccine-Derived Polioviruses in Individuals with Primary Immunodeficiency Diseases

Open access

Abstract

The oral poliovirus vaccine (OPV), which prevents person-to-person transmission of poliovirus by inducing robust intestinal immunity, has been a crucial tool for global polio eradication. However, polio outbreaks, mainly caused by type 2 circulating vaccine-derived poliovirus (cVDPV2), are increasing worldwide. Meanwhile, immunodeficiency-associated vaccine-derived poliovirus (iVDPV) is considered another risk factor during the final stage of global polio eradication. Patients with primary immunodeficiency diseases are associated with higher risks for long-term iVDPV infections. Although a limited number of chronic iVDPV excretors were reported, the recent identification of a chronic type 2 iVDPV (iVDPV2) excretor in the Philippines highlights the potential risk of inapparent iVDPV infection for expanding cVDPV outbreaks. Further research on the genetic characterizations and molecular evolution of iVDPV2, based on comprehensive iVDPV surveillance, will be critical for elucidating the remaining risk of iVDPV2 during the post-OPV era.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/v13071407

Cites

70 of 70 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 The phylogenetic tree of VP1 sequences in 157 iVDPV2 isolates. The sequence alignment was constructed using Clustal Omega, and the tree was inferred using the FastTree 2.1.10 [48] with the GTR model and gamma distribution and visualized with FigTree. Large genetic clusters of each case study are indicated by different colors, red for a chronic excretor in the United Kingdom 1995–2013 [45], blue for the environmental samples from Slovakia in 2003–2005 [43], and green for the stool and oropharyngeal samples from Israel in 2018 [46,47].
Figure 1 The phylogenetic tree of VP1 sequences in 157 iVDPV2 isolates. The sequence alignment was constructed using Clustal Omega, and the tree was inferred using the FastTree 2.1.10 [48] with the GTR model and gamma distribution and visualized with FigTree. Large genetic clusters of each case study are indicated by different colors, red for a chronic excretor in the United Kingdom 1995–2013 [45], blue for the environmental samples from Slovakia in 2003–2005 [43], and green for the stool and oropharyngeal samples from Israel in 2018 [46,47].CC BY · PubMed Central
Figure 2 The frequency of synonymous and non-synonymous substitutions of the VP1 amino acid sequences from 157 iVDPV2 and 567 cVDPV2 isolates. Sequence divergence was analyzed using SNAP (Synonymous Non-synonymous Analysis Program, https://www.hiv.lanl.gov/content/sequence/SNAP/SNAP.html (accessed on 28 May 2021)) [54]. The synonymous (blue crosses) and non-synonymous substitutions (red circles) of the VDPV sequence relative to the Sabin 2 strain are depicted. (A) iVDPV2. (B) cVDPV2.
Figure 2 The frequency of synonymous and non-synonymous substitutions of the VP1 amino acid sequences from 157 iVDPV2 and 567 cVDPV2 isolates. Sequence divergence was analyzed using SNAP (Synonymous Non-synonymous Analysis Program, https://www.hiv.lanl.gov/content/sequence/SNAP/SNAP.html (accessed on 28 May 2021)) [54]. The synonymous (blue crosses) and non-synonymous substitutions (red circles) of the VDPV sequence relative to the Sabin 2 strain are depicted. (A) iVDPV2. (B) cVDPV2.CC BY · PubMed Central
Figure 3 The number of amino acid substitutions in each position of the P1 capsid region of 19 iVDPV2 isolates. The amino acid substitutions in the neutralizing antigenic (NAg) sites are shown in red. The positions of hypervariable residues (HVRs) at the N-terminal and a gatekeeper substitution at VP1–143 of VP1 are indicated.
Figure 3 The number of amino acid substitutions in each position of the P1 capsid region of 19 iVDPV2 isolates. The amino acid substitutions in the neutralizing antigenic (NAg) sites are shown in red. The positions of hypervariable residues (HVRs) at the N-terminal and a gatekeeper substitution at VP1–143 of VP1 are indicated.CC BY · PubMed Central
Figure 4 The locations of amino acid substitutions in selected iVDPV2 isolates. The three-dimensional structure of type 2 wild poliovirus strain MEF-1 was obtained from PDB 1EAH and represented as a pentameric unit ((A): outside; (B): inside of capsid). Each protomer contains a single copy of VP1, VP2, VP3, and VP4 distinguished by gray colors. The location of frequent amino acid substitutions (more than 4 out of 19 iVDPV2 isolates) relative to the Sabin 2 strain is colored. The neutralizing antigenic sites are red. The hypervariable residues and the gatekeeper substitution of VP1-143 are green. Other amino acid changes are blue. The image was generated using PyMOL 2.4.2 (Schrödinger).
Figure 4 The locations of amino acid substitutions in selected iVDPV2 isolates. The three-dimensional structure of type 2 wild poliovirus strain MEF-1 was obtained from PDB 1EAH and represented as a pentameric unit ((A): outside; (B): inside of capsid). Each protomer contains a single copy of VP1, VP2, VP3, and VP4 distinguished by gray colors. The location of frequent amino acid substitutions (more than 4 out of 19 iVDPV2 isolates) relative to the Sabin 2 strain is colored. The neutralizing antigenic sites are red. The hypervariable residues and the gatekeeper substitution of VP1-143 are green. Other amino acid changes are blue. The image was generated using PyMOL 2.4.2 (Schrödinger).CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 70 references

Cited by

See all 14

Metadata

Authors
Kitamura, K., & Shimizu, H.
Affiliations
National Institute of Infectious Diseases (JP)
Corresponding author
Shimizu, Hiroyuki
Venue
Viruses
Publisher
MDPI AG
Published
2021-07-20
Volume
13
Issue
7
Pages
1407
ISSN
1999-4915 (ISSN-L)
OpenAlex
W3184160639
Cited by
14
References
70
Citations by year
2026: 1 · 2025: 1 · 2024: 3 · 2023: 5 · 2022: 4
FWCI
0.58
Type
journal article
Language
en
Open access
Locations
  • Viruses (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
Japan Agency for Medical Research and Development (JP21fk0108084)
Topics
  • Health Sciences › Medicine › Infectious Diseases › Viral Infections and Immunology Research
  • Health Sciences › Medicine › Epidemiology › Virology and Viral Diseases
  • Health Sciences › Medicine › Infectious Diseases › Viral gastroenteritis research and epidemiology
Keywords
primary immunodeficiency, oral polio vaccine, molecular evolution, polio eradication
MeSH terms
Primary Immunodeficiency Diseases, Disease Outbreaks, Humans, Poliovirus Vaccine, Oral, Vaccination, Global Health, Immunocompromised Host, Poliovirus, Evolution, Molecular, Disease Eradication

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The Molecular Evolution of Type 2 Vaccine-Derived Polioviruses in Individuals with Primary Immunodeficiency Diseases. https://app.cochat.ai/papers/10.3390/v13071407
The paper
Kitamura, K., & Shimizu, H. (2021). The Molecular Evolution of Type 2 Vaccine-Derived Polioviruses in Individuals with Primary Immunodeficiency Diseases. Viruses. https://doi.org/10.3390/v13071407

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.